Cargando…

Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review

The aim of this narrative review is to update the current knowledge on the differential choice of circulating cardiac biomarkers in patients with prediabetes and established type 2 diabetes mellitus (T2DM). There are numerous circulating biomarkers with unconfirmed abilities to predict clinical outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berezin, Alexander E., Berezin, Alexander A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261294/ https://www.ncbi.nlm.nih.gov/pubmed/32430864 http://dx.doi.org/10.1007/s13300-020-00835-9

Ejemplares similares

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
por: Berezin, Alexander E., et al.
Publicado: (2020)

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
por: Berezin, Alexander E.
Publicado: (2016)

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus
por: Berezin, Alexander E., et al.
Publicado: (2020)

The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation
por: Berezin, Alexander A., et al.
Publicado: (2022)

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Biomarkers in Heart Failure: From Research to Clinical Practice
por: Berezin, Alexander E., et al.
Publicado: (2023)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
por: Berezin, Alexander A., et al.
Publicado: (2022)

Editorial: Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score
por: Berezin, Alexander E., et al.
Publicado: (2021)

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
por: Berezin, Alexander E., et al.
Publicado: (2020)

Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezina, Tetiana A., et al.
Publicado: (2023)

Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2021)

Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
por: Berezin, Alexander A., et al.
Publicado: (2023)

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Analysis of Various Subsets of Circulating Mononuclear Cells in Asymptomatic Coronary Artery Disease
por: Berezin, Alexander E., et al.
Publicado: (2013)

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2015)

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

The signature of circulating microparticles in heart failure patients with metabolic syndrome
por: Berezin, Alexander E, et al.
Publicado: (2016)

Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease
por: Berezin, Alexander E., et al.
Publicado: (2016)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Epigenetics in heart failure phenotypes()
por: Berezin, Alexander
Publicado: (2016)

Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement
por: Boxhammer, Elke, et al.
Publicado: (2022)

Non-Coding RNAs: New Dawn for Diabetes Mellitus Induced Erectile Dysfunction
por: Xu, Wenchao, et al.
Publicado: (2022)

The utility of biomarker risk prediction score in patients with chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2016)

Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation
por: Berezin, Alexander E., et al.
Publicado: (2015)

Stable Coronary Artery Disease Patients: Different Practice Patterns in Everyday Clinical Situations
por: Berezin, Alexander E.
Publicado: (2015)

The predictive role of circulating microparticles in patients with chronic heart failure()
por: Berezin, Alexander E., et al.
Publicado: (2014)

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2014)

Novel Biomarkers and the Multiple-Marker Approach in Early Detection, Prognosis, and Risk Stratification of Cardiac Diseases: A Narrative Review
por: Ullah, Ashraf, et al.
Publicado: (2023)

Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations
por: Wu, Zhenqiang, et al.
Publicado: (2022)

The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2015)

A new DAWN: Improving the psychosocial management of diabetes
por: Holt, Richard I. G., et al.
Publicado: (2013)

Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2014)

The dawn of a new era
Publicado: (2017)

A new decade dawns
Publicado: (2010)

A new dawn for CMS
Publicado: (2007)

A new dawn in ICUrology
por: Park, Kwangsung
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vdtflnhhsm41bb7cmmp7fjr97v